Lv51
1543 积分 2023-10-27 加入
44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617—preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617
6天前
已完结
Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer
6天前
已完结
Combination of terbium-161 with somatostatin receptor antagonists—a potential paradigm shift for the treatment of neuroendocrine neoplasms
6天前
已完结
Application of 99mTc-Labeled WL12 Peptides as a Tumor PD-L1-Targeted SPECT Imaging Agent: Kit Formulation, Preclinical Evaluation, and Study on the Influence of Coligands
7天前
已完结
Sensitive Positron Emission Tomography Imaging of PD-L1 Expression in Human Breast and Lung Carcinoma Xenografts Using the Radiometalated Peptide Ga-68-TRAP-WL12
7天前
已完结
Preclinical evaluation and preliminary clinical study of 68Ga-NODAGA-NM-01 for PET imaging of PD-L1 expression
7天前
已完结
Peptide-based PET quantifies target engagement of PD-L1 therapeutics
7天前
已完结
Covalent targeted radioligands potentiate radionuclide therapy
1个月前
已完结
P53 Binding Protein 1 (53bp1) Is an Early Participant in the Cellular Response to DNA Double-Strand Breaks
3个月前
已完结
Radiotheranostic landscape: A review of clinical and preclinical development
3个月前
已完结
皖公网安备34019202002308
